Scinai Immunotherapeutics share price logo

Scinai Immunotherapeutics

NASDAQ: SCNI

$1.58

-0.04

(-2.45%)

Live

as on

Scinai Immunotherapeutics Stock Performance

as on September 19, 2026 at 5:06 am IST

  • Day's Low

    Day's High

    $1.57
    $1.77
    downward going graph

    0.63%

    Downside

    12.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.43
    $16.30
    downward going graph

    9.49%

    Downside

    931.65%

    Upside

    downward going graph

Scinai Immunotherapeutics share price movements today

Previous Close
$1.62
Open
$1.60
Volume
425.9K
Market Cap
$1.1M
Day's Low - High
$1.57 - $1.77
52 Week Low - High
$1.43 - $16.30

Scinai Immunotherapeutics Historical Returns

1 Month Return
-31.21 %
3 Month Return
-49.61 %
1 Year Return
-89.62 %
3 Year Return
-98.35 %
5 Year Return
0 %

Scinai Immunotherapeutics Stock Fundamentals & Key Indicators

Check Scinai Immunotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1M

EPS (TTM)

-62161.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.87%

PE Ratio (TTM)

0

Industry PE ratio

-2.37

PEG Ratio

6.293598003424595e-9

EBITDA

-6.7M

Revenue (TTM)

1.5M

Profit Margin

-252.45%

Return On Equity TTM

-26.63%

Scinai Immunotherapeutics Stock Valuation

Track how Scinai Immunotherapeutics P/E has moved over time to understand its valuation trends.

Scinai Immunotherapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-2.94x)

December 31, 2021

Industry (-2.37x)

March 31, 2026

Today (-0.20x)

March 31, 2026

Highest (0.56x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.20x

Scinai Immunotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Scinai Immunotherapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.1MNANA-252.45%0.00%
BUY$42.2B530.61%-22.230.00%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Scinai Immunotherapeutics Stock including INR - Dollar returns

The Scinai Immunotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Scinai Immunotherapeutics investment value today

Current value as on today

₹11,009

Returns

-₹88,991

(-88.99%)

Returns from Scinai Immunotherapeutics Stock

-₹89,872 (-89.87%)

Dollar Impact

₹880 (+0.88%)

Analyst Recommendation on Scinai Immunotherapeutics Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Scinai Immunotherapeutics. Average target price of $700

Scinai Immunotherapeutics Share Price Target

Get share price movements and forecasts by analysts on Scinai Immunotherapeutics.

What analysts predicted

99.77%UPSIDE

Target Price

$700

Current Price

$1.58

Analyzed by

7 Analysts

Target

$700.00

Scinai Immunotherapeutics target price $700, a slight upside of 99.77% compared to current price of $1.58. According to 7 analysts rating.

Indian Investors' Interest in Scinai Immunotherapeutics Stock

Search interest for Scinai Immunotherapeutics Stock has increased by 439% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:439% versus previous 30 day period

Scinai Immunotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
0
0
0
0
0
0
0
Gross Profit
-
0
-
0
0
0
0
0
-1
-1
Operating Income
-2
-1
-1
3
-2
-1
-1
-1
-2
-2
EBITDA
-1
-1
-1
-1
12
-1
-1
-1
-2
-1
Interest Expense
-
0
0
0
1
-
0
-
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
3
-2
-2
-2
10
-1
-2
-2
3
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
3
-2
-2
-2
10
-1
-2
-2
3
-2
Net Profit Margin
0.00%
0.00%
0.00%
-57.75%
-148.21%
38.91%
-164.29%
-256.88%
-228.63%
-272.17%

Scinai Immunotherapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Mar 2020
Mar 2021
Dec 2021
Mar 2023
Dec 2023
Mar 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
0
1
Gross Profit
-
-
-
0
0
-
-
0
-2
Operating Income
-6
-20
-22
-19
-10
-11
-9
-8
-7
EBITDA
-6
-20
-22
-19
-10
-5
-2
-6
-6
Interest Expense
0
3
4
0
3
-
3
1
0
Depreciation
0
0
0
0
0
0
0
1
1
Income Before Tax
-9
-23
-31
-1
-12
-5
-6
4
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-9
-23
-31
-1
-12
-5
-6
4
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-88.15%
-202.29%

Scinai Immunotherapeutics Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
3
-2
-2
-2
10
-1
-2
-2
3
-2
Operating Cash Flow
-2
-1
-1
-1
-2
-1
-1
-1
-1
-2
Investing Cash Flow
0
0
0
0
0
0
0
0
2
0
Financing Cash Flow
1
-
1
0
0
0
1
2
0
2
Change in Cash
-1
-1
0
-1
-2
0
0
-
1
0

Scinai Immunotherapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Mar 2020
Mar 2021
Dec 2021
Mar 2023
Dec 2023
Mar 2025
Mar 2026
Net Income
-9
-23
-31
-1
-8
-5
-6
4
-8
Operating Cash Flow
-2
-15
-22
-21
-7
-7
-9
-6
-6
Investing Cash Flow
1
-6
-2
-1
0
0
0
0
0
Financing Cash Flow
17
22
24
3
21
6
1
3
5
Change in Cash
16
0
0
-18
14
-3
-9
-2
0

Global Institutional Holdings in Scinai Immunotherapeutics

Funds
Holdings
XTX Topco Ltd
0.61%
TWO SIGMA SECURITIES, LLC
0%
Rhumbline Advisers
0.05%
UBS Group AG
0.02%
Morgan Stanley - Brokerage Accounts
0%

Scinai Immunotherapeutics News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 08:00 PM

    -

    Scinai Immunotherapeutics ends PC111 deal, refocusing on NanoAb platform and CDMO growth with $3.1 million in customer orders.

Insights on Scinai Immunotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 521.1% return, outperforming this stock by 610.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 51.8% return, outperforming this stock by 150.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SCNI stock has moved down by -31.2%

About Scinai Immunotherapeutics

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis. The company also offers contract development and manufacturing organization services, such as analytical method development, process development, and cGMP manufacturing of clinical-stage materials to early-stage biotechnology companies. It has collaboration partnerships with Max Planck Society and University Medical Center Gottingen for the development of NanoAb candidates; and Recipharm Israel Ltd for the development of biologics and small-molecule programs. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is based in Jerusalem, Israel.
OrganisationScinai Immunotherapeutics
HeadquartersJerusalem BioPark, Jerusalem, Israel
IndustryBiotechnology
CEOMr. Amir Reichman M.B.A., M.Sc.
E-voting on sharesClick here to vote

Key Management of Scinai Immunotherapeutics

Name

Title

Mr. Elad Mark B.Sc., Eng., M.B.A.

Chief Operating Officer

Gal Ron

Head of HR

Merav Kamensky

Head of Quality Control & GMP Analytics

Dr. Naama Adi Hen

Head of Quality Asurance

Mr. Eran Kuratz

Head of Supply Chain & Business Process Administration

Mr. Amir Reichman M.B.A., M.Sc.

CEO & Director

Mr. Uri Ben-Or CPA, M.B.A.

Chief Financial Officer

FAQs

What is Scinai Immunotherapeutics share price today?

Scinai Immunotherapeutics share price today is $1.58 as on . Scinai Immunotherapeutics share today touched a day high of $1.77 and a low of $1.57.

What is the 52 week high and 52 week low for Scinai Immunotherapeutics share?

Scinai Immunotherapeutics share touched a 52 week high of $16.30 on and a 52 week low of $1.43 on . Scinai Immunotherapeutics stock price today i.e. is trending at $1.58,which is 90.31% down from its 52 week high and 10.49% up from its 52 week low.

What is Scinai Immunotherapeutics's market capitalisation today?

Scinai Immunotherapeutics market capitalisation is $0.00T as on .

How to invest in Scinai Immunotherapeutics Stock (SCNI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Scinai Immunotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Scinai Immunotherapeutics Shares that will get you 0.9494 shares as per Scinai Immunotherapeutics share price of $1.58 per share as on September 18, 2026 at 11:36 pm IST.

What is the minimum amount required to buy Scinai Immunotherapeutics Stock (SCNI) from India?

Indian investors can start investing in Scinai Immunotherapeutics (SCNI) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Scinai Immunotherapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Scinai Immunotherapeutics share’s latest price of $1.58 as on September 18, 2026 at 11:36 pm IST, you will get 6.3291 shares of Scinai Immunotherapeutics. Learn more about fractional shares .